The Sunshine Act — Effects on Physicians

Agrawal, Shantanu; Brennan, Niall; Budetti, Peter P.

doi:10.1056/nejmp1303523

Cited by 160 publications

(114 citation statements)

References 1 publication

Supporting

Mentioning

112

Contrasting

Unclassified

Order By: Relevance

“…Incorrect payments were documented in the first year (2013) of the Sunshine Act, with data reported by 1,347 companies, of which 1,228 submitted at least one payment record with varying physician identifiers. 1 As a result of such inaccuracies, $2.2 billion worth of 2013 payments went unpublished. 18 For the second year (2014), algorithms were implemented by the CMS to confirm the physician data with additional sources; as a result, 98.8% of submitted payment information was successfully confirmed.…”

Section: Discussionmentioning

confidence: 99%

“…In essence (subject to certain qualifications such as sample medications, discounts, and rebates), the payments made by the medical industry to medical practitioners and hospital staff, in terms of gifts, research funding, medical education, or consultancy, must be reported to the Centers for Medicare and Medicaid Services (CMS), the database for the Act. 1 As many as 94% of US physicians maintain some financial relationships with the industry. 2,3 Driven by public interest in the disclosure of the extent of these financial relationships, the Sunshine Act is an important step in both quantifying these ties and shedding light on potential conflicts of interest and influence of the industry's payments on practice patterns.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of Industrial Compensation to Cardiologists in 2015

Khan

Siddiqi

Fatima

et al. 2017

The American Journal of Cardiology

View full text Add to dashboard Cite

The categorization and characterization of pharmaceutical and device manufacturers or group purchasing organization payments to clinicians is an important step toward assessing conflicts of interest and the potential impact of these payments on practice patterns. Payments have not previously been compared among the subspecialties of cardiology. This is a retrospective analysis of the Open Payments database, including all installments and payments made to doctors in the calendar year 2015 by pharmaceutical and device manufacturers or group purchasing organization. Total payments to individual physicians were then aggregated based on specialty, geographic region, and payment type. The Gini Index was further employed to calculate within each specialty to measure income disparity. In 2015, a total of $166,089,335 was paid in 943,744 payments (average $175.00 per payment) to cardiologists, including 23,372 general cardiologists, 7,530 interventional cardiologists, and 2,293 cardiac electro-physiologists. Payments were mal-distributed across the 3 subspecialties of cardiology (p <0.01), with general cardiology receiving the largest number (73.5%) and total payments (62.6%) and cardiac electrophysiologists receiving significantly higher median payments ($1,662 vs $361 for all cardiologists; p <0.01). The Medtronic Company was the largest single payer for all 3 subspecialties. In conclusion, pharmaceutical and device manufacturers or group purchasing organizations continue to make substantial payments to cardiac practitioners with a significant variation in payments made to different cardiology subspecialists. The largest number and total payments are to general cardiologists, whereas the highest median payments are made to cardiac electrophysiologists. The impact of these payments on practice patterns remains to be examined.

show abstract

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

Evaluation of Industrial Compensation to Cardiologists in 2015

Khan

Siddiqi

Fatima

et al. 2017

The American Journal of Cardiology

View full text Add to dashboard Cite

show abstract

“…Previous studies of self-disclosure of financial relationships have shown substantial reporting inaccuracies among orthopaedic surgeons [7], and other physician specialties [36,39]. To address this, the newly passed Physician Patient Sunshine Act, part of the larger Patient Protection and Affordable Care Act, mandates that all industry payments made to physicians from drug or device manufacturers or GPOs be reported to the Centers for Medicare and Medicaid Services (CMS) [1,31]. The initial release of data was made on September 30, 2014, containing data on payments made between August 1, 2013 and December 31, 2013, with a second release on December 19, 2014 providing additional initially disputed payment data from the same period.…”

Section: Introductionmentioning

confidence: 99%

Orthopaedic Surgeons Receive the Most Industry Payments to Physicians but Large Disparities are Seen in Sunshine Act Data

Samuel

Webb

Lukasiewicz

et al. 2015

Clin Orthop Relat Res

View full text Add to dashboard Cite

Background Industry payments made to physicians by drug and device manufacturers or group purchasing organizations are now reported to the Centers for Medicare and Medicaid Services (CMS) as a part of the Physician Payments Sunshine Act. Initial reports from the program show that orthopaedic surgeons lead all physician specialties in total and average industry payments. However, before further discussion of these payments and their implications can take place, it remains to be seen whether these figures are a true reflection of the field of orthopaedic surgery in general, rather than the result of a few outlier physicians in the field. In addition, the nature and sources of these funds should be determined to better inform the national dialogue surrounding these payments.

show abstract

“…Data collection began in August of 2013, with initial data release in September of 2014. 8,9 We used Open Payments data to describe pediatrician-industry ties by (1) comparing payments between pediatricians and other medical specialties, (2) examining variation in ties among pediatric subspecialties, and (3) identifying the types of payment and the drugs or devices associated with payments to pediatricians.…”

mentioning

confidence: 99%

Industry Relationships With Pediatricians: Findings From the Open Payments Sunshine Act

2016

Self Cite

View full text Add to dashboard Cite

BACKGROUND AND OBJECTIVES:Ties between physicians and pharmaceutical/medical device manufactures have received considerable attention. The Open Payments program, part of the Affordable Care Act, requires public reporting of payments to physicians from industry. We sought to describe payments from industry to physicians caring for children by (1) comparing payments to pediatricians to other medical specialties, (2) determining variation in payments among pediatric subspecialties, and (3) identifying the types of payment and the products associated with payments to pediatricians.

show abstract

The Sunshine Act — Effects on Physicians

Cited by 160 publications

References 1 publication

Evaluation of Industrial Compensation to Cardiologists in 2015

Evaluation of Industrial Compensation to Cardiologists in 2015

Orthopaedic Surgeons Receive the Most Industry Payments to Physicians but Large Disparities are Seen in Sunshine Act Data

Industry Relationships With Pediatricians: Findings From the Open Payments Sunshine Act

Contact Info

Product

Resources

About